Moderate-risk variants in hereditary breast and ovarian cancer: seven-year experience from a specialized center
Moderate-risk gene variants represent an increasingly recognized component of hereditary breast and ovarian cancer (HBOC) predisposition, yet their clinical interpretation and management remain less standardized than those of high-penetrance genes. This study provides a seven-year real-world evaluation of genetic varia...